Application 085762
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE | TABLET;ORAL | 0.025MG;2.5MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | Approved before 1982 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A085762-001 | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG;2.5MG | TABLET / ORAL | AA | Approved before 1982 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A085762-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A085762-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A085762-001 | AA | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A085762-001 | AA | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A085762-001 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A085762-001 | AA | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A085762-001 | AA | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A085762-001 | AA | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A085762-001 | AA | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A085762-001 | AA | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A085762-001 | AA | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A085762-001 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A085762-001 | AA | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A085762-001 | AA | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A085762-001 | AA | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A085762-001 | AA | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A085762-001 | AA | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A085762-001 | AA | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A085762-001 | AA | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A085762-001 | AA | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A085762-001 | AA | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A085762-001 | AA | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A085762-001 | AA | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A085762-001 | AA | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A085762-001 | AA | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A085762-001 | AA | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-0415 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0415 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0615-7801 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | Current |
| 12634-531 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | Apotheca Inc. | ANDA | Current |
| 21695-688 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | Rebel Distributors Corp | ANDA | Current |
| 33261-685 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | Aidarex Pharmaceuticals LLC | ANDA | Current |
| 43063-089 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-089 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-089 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-089 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 50090-0039 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | A-S Medication Solutions | ANDA | Current |
| 50090-0039 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | A-S Medication Solutions | ANDA | Current |
| 50090-0040 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | A-S Medication Solutions | ANDA | Current |
| 55289-102 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-102 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 55289-102 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 63187-254 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | Proficient Rx LP | ANDA | Current |
| 63187-254 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | Proficient Rx LP | ANDA | Current |
| 66267-082 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | NuCare Pharmaceuticals, Inc. | ANDA | Current |
| 66267-082 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | NuCare Pharmaceuticals, Inc. | ANDA | Current |
| 66267-780 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | NuCare Pharmaceuticals, Inc. | ANDA | Current |
| 66267-780 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | NuCare Pharmaceuticals, Inc. | ANDA | Current |
| 66336-437 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | Dispensing Solutions, Inc. | ANDA | Current |
| 67296-0505 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | RedPharm Drug, Inc. | ANDA | Current |
| 67544-021 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 68788-9135 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | Preferred Pharmaceuticals, Inc. | ANDA | Current |
| 70518-0919 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | REMEDYREPACK INC. | ANDA | Current |
| 70518-0919 | Diphenoxylate Hydrochloride and Atropine Sulfate | diphenoxylate hydrochloride and atropine sulfate | REMEDYREPACK INC. | ANDA | Current |